Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$832M |
| 2 |
Johnson & Johnson
JNJ
|
+$706M |
| 3 |
Datadog
DDOG
|
+$549M |
| 4 |
Amazon
AMZN
|
+$442M |
| 5 |
Eli Lilly
LLY
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$1.22B |
| 2 |
AbbVie
ABBV
|
+$1.07B |
| 3 |
Advanced Micro Devices
AMD
|
+$817M |
| 4 |
Amgen
AMGN
|
+$706M |
| 5 |
Honeywell
HON
|
+$659M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.69% |
| 2 | Healthcare | 17.58% |
| 3 | Consumer Discretionary | 10.69% |
| 4 | Financials | 10.23% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Travelers Companies
TRV
$82.4B
| $79.8M | 0.04% |
331,325
-8,576
| -3% | -$2.14M |
|
302
Liberty Media Series A
FWONA
$23.4B
| $79.7M | 0.04% |
948,907
+4,641
| +0.5% | +$361K |
|
303
CACI
CACI
$10.9B
| $79.3M | 0.04% |
196,384
+9,420
| +5% | +$4.59M |
|
304
Silgan Holdings
SLGN
$4.47B
| $78.9M | 0.04% |
1,515,582
+401,890
| +36% | +$21.4M |
|
|
VRNA
305
DELISTED
Verona Pharma
VRNA
| $77.5M | 0.04% |
1,667,165
+624,370
| +60% | +$23.4M |
|
306
Disc Medicine
IRON
$2.81B
| $77.2M | 0.04% |
1,217,815
+467,988
| +62% | +$27.1M |
|
307
Lattice Semiconductor
LSCC
$16.3B
| $76.8M | 0.04% |
1,357,119
+1,195,624
| +740% | +$65.6M |
|
308
AST SpaceMobile
ASTS
$16.6B
| $76.7M | 0.04% |
3,635,711
+6,626
| +0.2% | +$162K |
|
309
ExxonMobil
XOM
$654B
| $76.4M | 0.04% |
709,539
+132,507
| +23% | +$15.5M |
|
310
Bank of America
BAC
$435B
| $75.8M | 0.04% |
1,723,030
+632,988
| +58% | +$27.8M |
|
311
Advanced Drainage Systems
WMS
$10.7B
| $74.4M | 0.04% |
644,056
+54,916
| +9% | +$7.62M |
|
312
American Homes 4 Rent
AMH
$12.2B
| $73.8M | 0.04% |
1,973,969
+38,962
| +2% | +$1.46M |
|
313
CGI
GIB
$15.6B
| $73.7M | 0.04% |
673,206
-14,341
| -2% | -$1.61M |
|
314
Churchill Downs
CHDN
$6.23B
| $72.9M | 0.04% |
545,912
+94,351
| +21% | +$13.1M |
|
315
Welltower
WELL
$173B
| $72.8M | 0.04% |
578,584
-534,528
| -48% | -$70.2M |
|
316
Bio-Techne
TECH
$11.2B
| $72.7M | 0.04% |
1,009,471
+12,305
| +1% | +$904K |
|
317
Entergy
ETR
$51.1B
| $72.6M | 0.04% |
957,111
-127,051
| -12% | -$9.17M |
|
318
Descartes Systems
DSGX
$6.67B
| $72.2M | 0.04% |
635,722
+3,554
| +0.6% | +$396K |
|
319
CBRE Group
CBRE
$44.1B
| $71.7M | 0.04% |
546,189
-107,089
| -16% | -$14M |
|
320
Praxis Precision Medicines
PRAX
$8.21B
| $71.6M | 0.04% |
929,523
+405,957
| +78% | +$29.4M |
|
321
Travere Therapeutics
TVTX
$5.13B
| $70.7M | 0.04% |
4,058,632
+4,026,819
| +12,658% | +$71.2M |
|
322
Fox Class B
FOX
$22B
| $70.3M | 0.04% |
1,536,614
-179,551
| -10% | -$7.56M |
|
323
Legend Biotech
LEGN
$3.64B
| $70.2M | 0.04% |
2,156,749
-28,885
| -1% | -$1.2M |
|
324
Lazard
LAZ
$4.06B
| $70.1M | 0.04% |
1,361,366
-150,683
| -10% | -$8.07M |
|
325
Ventas
VTR
$47.6B
| $68.7M | 0.03% |
1,166,840
+1,076,803
| +1,196% | +$67.7M |
|
Similar funds
Janus Henderson Group's Q4 2024 Portfolio in Review
As of Q4 2024, Janus Henderson Group held 2,620 positions worth $197B, up 0.7% from $195B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Janus Henderson Group's Q4 2024 filing shows 92 new, 801 increased, 713 reduced and 96 closed positions. Its largest new stake was Lam Research: 10,967,975 shares worth $792M. The largest sale was Workday, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2024 buy was Lam Research: 10,967,975 shares worth $792M.
- Janus Henderson Group added most to Johnson & Johnson in Q4 2024, an estimated $706M increase.
- Janus Henderson Group's biggest Q4 2024 reduction was Workday, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Coca-Cola Europacific Partners in Q4 2024, selling an estimated $52.4M.
- Janus Henderson Group's ten largest holdings make up 32% of its $197B portfolio in Q4 2024.
- Janus Henderson Group opened 92 new positions and closed 96 in Q4 2024.
- Janus Henderson Group's portfolio value rose 0.7% quarter-over-quarter to $197B.
Based on Janus Henderson Group's 13F filing for Q4 2024, filed 14 Feb 2025.